A Single-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Assess the Effect of Vildagliptin on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
Latest Information Update: 17 Sep 2021
Price :
$35 *
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novartis
- 11 Sep 2008 Results have been published in the proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes.
- 12 Aug 2008 Actual completion date for this trial is now 1 Nov 2007 as reported by ClinicalTrials.gov.
- 07 Aug 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.